Edwards Lifesciences
EW
$84.41
Share price
3.69%
Change (1 day)
-16.30%
Change (1 year)
Categories
Revenue for Edwards Lifesciences (EW)
Revenue in 2023 (TTM): $5.50 B
According to Edwards Lifesciences's latest financial reports the company's current revenue (TTM) is $5.50 B. In 2022 the company made a revenue of $5.38 B an increase over the years 2021 revenue that were of $5.23 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Edwards Lifesciences from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $5.50 B | 2.2% |
| 2022 | $5.38 B | 2.86% |
| 2021 | $5.23 B | 19.29% |
| 2020 | $4.38 B | 0.88% |
| 2019 | $4.34 B | 16.79% |
| 2018 | $3.72 B | 8.37% |
| 2017 | $3.43 B | 15.91% |
| 2016 | $2.96 B | 18.85% |
| 2015 | $2.49 B | 7.35% |
| 2014 | $2.32 B | 13.56% |
| 2013 | $2.04 B | 7.68% |
| 2012 | $1.89 B | 13.17% |
| 2011 | $1.67 B | 16.01% |
| 2010 | $1.44 B | 9.51% |
| 2009 | $1.32 B | 6.76% |
| 2008 | $1.23 B | 13.44% |
| 2007 | $1.09 B | 5.19% |
| 2006 | $1.03 B | 3.95% |
| 2005 | $0.99 B | 7.13% |
| 2004 | $0.93 B | 8.25% |
| 2003 | $0.86 B | 22.23% |
| 2002 | $0.70 B | 1.73% |
| 2001 | $0.69 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | $30.77 B | 459.41% | 🇮🇪 Ireland |
 Boston Scientific BSX | $13.04 B | 137.15% | 🇺🇸 USA |
 Merit Medical MMSI | $1.17 B | -78.67% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | $0.16 B | -96.92% | 🇺🇸 USA |
 ICU Medical
ICUI | $2.30 B | -58.09% | 🇺🇸 USA |
 CryoLife CRY | $0.29 B | -94.57% | 🇺🇸 USA |